HomeVKTX • NASDAQ
add
Viking Therapeutics Inc
Previous close
$68.86
Day range
$68.22 - $74.64
Year range
$8.28 - $99.41
Market cap
8.19B USD
Avg Volume
3.95M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Top news
Q1 earnings report for Viking Therapeutics
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 34.07M | 65.91% |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | -0.26 | -4.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 962.98M | 609.82% |
Total assets | 967.52M | 541.19% |
Total liabilities | 33.63M | 99.80% |
Total equity | 933.89M | — |
Shares outstanding | 110.23M | — |
Price to book | 8.13 | — |
Return on assets | -12.75% | — |
Return on capital | -13.26% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | — | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2012
Website
Employees
28